Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Preclinical Evaluation of <sup>177</sup>Lu-Labeled Anti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer.

Molecular pharmaceutics·2026

Same author

Rehabilitation assessment of upper limb motor function in stroke patients based on semi-quantitative information.

Frontiers in robotics and AI·2026

Same author

Porcine Parvovirus virus-like particle vaccine induces long-term humoral immunity by recruiting T follicular helper and germinal center B cell responses.

Frontiers in immunology·2026

Same author

Development and Evaluation of an Albumin-Binding GPC3-Targeting Peptide for PET Imaging of Hepatocellular Carcinoma.

Molecular pharmaceutics·2026

Same author

Cascaded deep learning enables multimodal brain PET spatial normalization and quantification for Alzheimer's disease.

NeuroImage·2026

Same author

Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review.

Frontiers in immunology·2026

Search research articles

Related Experiment Video

Updated: Aug 12, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Antibody theranostics in precision medicine.

Qianyun Wu¹, Shaowen Yang², Jianjun Liu¹

¹Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200217, China.

Med (New York, N.Y.)

|February 1, 2023

Summary

Antibody theranostics integrates diagnostics and therapeutics for targeted treatments. This approach enhances patient stratification and treatment response assessment in precision medicine.

More Related Videos

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Related Experiment Videos

Last Updated: Aug 12, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Area of Science:

Immunology
Nuclear Medicine
Oncology

Background:

Antibody therapeutics are increasingly utilized in clinical practice.
Precise patient stratification and timely treatment response assessment remain significant challenges.
Current diagnostic and therapeutic strategies often operate independently.

Purpose of the Study:

To introduce and define antibody theranostics.
To highlight the potential of antibody theranostics in precision medicine.
To emphasize the integration of diagnostics and therapeutics.

Main Methods:

Combining radionuclides with antibodies or their derivatives.
Systematic integration of targeted diagnostics and therapeutics.
Leveraging antibody targeting for both imaging and therapy.

Main Results:

Antibody theranostics offers a unified approach to patient management.
Enables simultaneous diagnostic assessment and therapeutic intervention.
Potential for improved therapeutic efficacy and reduced toxicity.

Conclusions:

Antibody theranostics represents a significant advancement in targeted medicine.
This integrated approach is poised to play a crucial role in the future of precision medicine.
Facilitates personalized treatment strategies based on individual patient profiles.